Importantly, knockdown of NANOG/NANOGP8 mRNA in cancer cells inhibits tumorigenesis and clonogenic growth of breast, colon, prostate, and gastrointestinal cancer cell lines (Jeter et al. 2009; Jeter et al. 2011; Uchino et al. 2012). Here, NANOGP8 is linked to cancer.